MNA
GSK icon

Manning & Napier Advisors’s GSK GSK Stock Holding History

Manning & Napier Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6M Buy
277,309
+41,832
+18% +$2.21M 0.19% 82
2026
Q1 		$13M Sell
235,477
-1,414,827
-86% -$76.7M 0.18% 87
2025
Q4 		$81.4M Sell
1,650,304
-201,265
-11% -$9.39M 1.06% 34
2025
Q3 		$79.9M Buy
1,851,569
+1,668,277
+910% +$65.2M 1.02% 31
2025
Q2 		$7.04M Sell
183,292
-16,708
-8% -$638K 0.08% 146
2025
Q1 		$7.75M Hold
200,000
– – 0.1% 135
2024
Q4 		$6.76M Buy
200,000
+50,000
+33% +$1.8M 0.08% 141
2024
Q3 		$6.13M Hold
150,000
– – 0.07% 167
2024
Q2 		$5.78M Buy
+150,000
New +$6.31M 0.07% 161
2015
Q2 		– Sell
-279,684
Closed -$16.1M – 370
2015
Q1 		$16.1M Sell
279,684
-5,579
-2% -$320K 0.08% 128
2014
Q4 		$15.2M Buy
285,263
+18,495
+7% +$1.03M 0.07% 136
2014
Q3 		$15.3M Buy
266,768
+1,533
+0.6% +$94K 0.06% 139
2014
Q2 		$17.7M Buy
265,235
+1,993
+0.8% +$135K 0.07% 128
2014
Q1 		$17.6M Sell
263,242
-43,716
-14% -$2.96M 0.07% 124
2013
Q4 		$20.5M Sell
306,958
-13,171
-4% -$854K 0.09% 108
2013
Q3 		$20.1M Buy
320,129
+3,950
+1% +$254K 0.09% 103
2013
Q2 		$19.7M Buy
+316,179
New +$20.1M 0.11% 95

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Manning & Napier Advisors's GSK Position: Q2 2026 in Review

Manning & Napier Advisors increased its GSK (GSK) stake by 18% in Q2 2026, buying an estimated $2.21M and bringing the position to 277,309 shares worth $14.6M. The position accounts for 0.19% of the portfolio, ranked #82.

Manning & Napier Advisors first reported a position in GSK in Q2 2013 and has held it in 17 quarters since. The position peaked at $81.4M in Q4 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Manning & Napier Advisors held 277,309 shares of GSK worth $14.6M as of Q2 2026.
  • Manning & Napier Advisors bought 41,832 GSK shares in Q2 2026, an estimated $2.21M.
  • GSK made up 0.19% of Manning & Napier Advisors's portfolio in Q2 2026, its #82 holding.
  • Manning & Napier Advisors first reported a position in GSK in Q2 2013 and has held it in 17 quarters since.
  • Manning & Napier Advisors's GSK position peaked at $81.4M in Q4 2025.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.